2025-08-13 12:52:55
Latest Post
Weaver Services completes acquisition of Capital India Home Loans after regulatory approval
Affordable Robotic and Automation Limited Reports Year-on-Year Improvement in Q1 FY2026 Performance
Elara Capital CPI Report - Benign CPI leaves room for another rate cut
Calcom Vision Reports Q1 FY26 PAT at Rs 0.69 Crore, up 138.72% YoY; Revenue from Operations Rises 146.82% YoY to Rs 45.07crore
Nazara Doubles Q1FY26 Revenues to ₹498.8 Cr, EBITDA Up 90% to ₹47.4 Cr and PAT Increases by 118% to ₹51.3 Cr
Stock Report
Neuland Laboratories Ltd receives EIR from USFDA for Unit 2 at Pashamylaram Village
Posted On : 2025-06-28 18:58:40( TIMEZONE : IST )
The U.S.FDA has issued an Establishment Inspection Report (EIR) against the Inspection conducted at our Unit 2 manufacturing facility, located at Pashamylaram village, Sangareddy District, from April 28, 2025 to May 2, 2025.
Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 12118.80 as compared to the previous close of Rs. 11961.05. The total number of shares traded during the day was 786 in over 278 trades.
The stock hit an intraday high of Rs. 12175.10 and intraday low of 11908.60. The net turnover during the day was Rs. 9483615.00.
